MoneyWorks4Me

Lupin - Quaterly Results

14 May 2025 Evaluate
A decent increase of about 32.09% in the sales to Rs. 44856.70 millions was observed for the quarter ended March 2025. The sales figure stood at Rs. 33958.80 millions during the year-ago period.The Net Profit of the company reported a remarkable increase of 236.22% to Rs. 12913.50  millions  from Rs. 3840.80 millions in previous same quarter.Operating Profit saw a handsome growth to 17949.20 millions from 7316.90 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 44856.70 33958.80 32.09 169675.00 146665.00 15.69 169675.00 146665.00 15.69
Other Income 487.90 313.40 55.68 1740.50 1067.30 63.08 1740.50 1067.30 63.08
PBIDT 17949.20 7316.90 145.31 56465.30 35657.90 58.35 56465.30 35657.90 58.35
Interest 338.50 134.90 150.93 845.00 563.50 49.96 845.00 563.50 49.96
PBDT 17610.70 7182.00 145.21 54848.10 35094.40 56.29 54848.10 35094.40 56.29
Depreciation 2079.80 2900.40 -28.29 6476.90 7247.50 -10.63 6476.90 7247.50 -10.63
PBT 15530.90 4281.60 262.74 48371.20 27846.90 73.70 48371.20 27846.90 73.70
TAX 2617.40 440.80 493.78 8641.60 4586.00 88.43 8641.60 4586.00 88.43
Deferred Tax -85.10 -249.80 -65.93 70.40 -254.50 -127.66 70.40 -254.50 -127.66
PAT 12913.50 3840.80 236.22 39729.60 23260.90 70.80 39729.60 23260.90 70.80
Equity 913.20 911.40 0.20 913.20 911.40 0.20 913.20 911.40 0.20
PBIDTM(%) 40.01 21.55 85.71 33.28 24.31 36.88 33.28 24.31 36.88
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..